EGFR and cancer: Thus, as previous results have suggested, autophagy may be a double-edge sword capable of either promoting or restraining the survival of EGFRM+ NSCLC cells in hypoxic situations and the EGFR signaling may be a key modulator of the switch between cancer cell survival and death in these conditions [252,253].